DOCSLIB.ORG

Transient Receptor Potential Channels As Drug Targets: from the Science of Basic Research to the Art of Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Transient Receptor Potential Channels As Drug Targets: from the Science of Basic Research to the Art of Medicine 1521-0081/66/3/676–814$25.00 http://dx.doi.org/10.1124/pr.113.008268 PHARMACOLOGICAL REVIEWS Pharmacol Rev 66:676–814, July 2014 Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics ASSOCIATE EDITOR: DAVID R. SIBLEY Transient Receptor Potential Channels as Drug Targets: From the Science of Basic Research to the Art of Medicine Bernd Nilius and Arpad Szallasi KU Leuven, Department of Cellular and Molecular Medicine, Laboratory of Ion Channel Research, Campus Gasthuisberg, Leuven, Belgium (B.N.); and Department of Pathology, Monmouth Medical Center, Long Branch, New Jersey (A.S.) Abstract. ....................................................................................679 I. Transient Receptor Potential Channels: A Brief Introduction . ...............................679 A. Canonical Transient Receptor Potential Subfamily . .....................................682 B. Vanilloid Transient Receptor Potential Subfamily . .....................................686 C. Melastatin Transient Receptor Potential Subfamily . .....................................696 Downloaded from D. Ankyrin Transient Receptor Potential Subfamily .........................................700 E. Mucolipin Transient Receptor Potential Subfamily . .....................................702 F. Polycystic Transient Receptor Potential Subfamily . .....................................703 II. Transient Receptor Potential Channels: Hereditary Diseases (Transient Receptor Potential Channelopathies). ......................................................704 at Open University Library on January 18, 2020 A. Canonical Transient Receptor Potential Channelopathies. ...............................704 B. Vanilloid Transient Receptor Potential Channelopathies. ...............................705 C. Melastatin Transient Receptor Potential Channelopathies . ...............................708 D. Ankyrin Transient Receptor Potential Channelopathies . ...............................710 E. Mucolipin Transient Receptor Potential Channelopathies. ...............................710 F. Polycystic Transient Receptor Potential Channelopathies . ...............................711 III. Transient Receptor Potential Channels: Acquired Diseases ...................................712 A. The Role of Transient Receptor Potential Channels in Nociception, Pain, and Itch . .......713 1. Basic Concepts .......................................................................713 a. Differential transient receptor potential channel expression defines functional sensory neuron subtypes: Implications for drug development. ...................717 b. Disease-related changes in transient receptor potential channel expression. .......718 2. Transient Receptor Potential Channels in Dental Pain . ...............................720 3. Transient Receptor Potential Channels in Visceral Pain...............................722 a. Esophagus and gastrointestinal tract. ..........................................722 b. Genitourinary tract.. ............................................................725 4. Contribution of Transient Receptor Potential Channels to Neuropathic and Cancer Pain . 727 a. Targeting vanilloid transient receptor potential 1 for pain relief: A brief overview of clinical studies. ................................................727 b. Vanilloid transient receptor potential 3. ..........................................733 c. Melastatin transient receptor potential 8. .........................................734 d. Ankyrin transient receptor potential 1. ..........................................735 5. The Contribution of Transient Receptor Potentials to Chemotherapy-Induced Neuropathic Pain . ..................................................................736 6. Transient Receptor Potential Channels in Migraine ...................................738 a. The role of vanilloid transient receptor potential 1 in migraine and cluster headache.. 738 b. Ankyrin transient receptor potential 1 as a candidate sensor for environmental irritants that provoke migraine attacks. .........................740 Address correspondence to: Arpad Szallasi, Department of Pathology, Monmouth Medical Center, 300 Second Avenue, Long Branch, NJ 07740. E-mail: [email protected] dx.doi.org/10.1124/pr.113.008268. 676 TRP Channels as Drug Targets 677 c. Possible Involvement of other transient receptor potential channels in migraine. 740 d. Migraine as a transient receptor potential channelopathy? .........................740 ABBREVIATIONS: 2-APB, 2-aminoethoxydiphenyl borate; 4aPDD, 4a-phorbol 12,13-didecanoate; A-1165442, (R)-1-(7-chloro-2,2-bis(fluoro- methyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea; A-784168, 3,6-dihydro-39-(trifluoromethyl)-N-[4-[(trifluoromethyl)sulfonyl]phenyl]-[1(2H),29- bipyridine]-4-carboxamide; A-795614, 1-(1H-indazol-4-yl)-3-[(1R)-5-piperidin-1-yl-2,3-dihydro-1H-inden-1-yl]urea; A-889425, 1-(3-methylpyridin-2-yl)- N-(4-(trifluoromethylsulfonyl)phenyl)-1,2,3,6-tetrahydropyridine-4-carboxamide; A-967079, (1E,3E)-1-(4-fluorophenyl)-2-methyl-1-pentene-3-one oxime; A-993610, (S)-1-(3-chloropyridin-2-yl)-3-methyl-N-(4-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine-4-carboxamide; ABT-102, (R)-(5-tert- butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea; ABT-116, urea, N-((2-(3,3-dimethylbutyl)-4-(trifluoromethyl)phenyl)methyl)-N9-(1-methyl- 1H-indazol-4-yl); ADPKD, autosomal dominant polycystic kidney disease; ADPR, ADP-ribose; AKAP, A-kinase–anchoring protein; ALS-G, Guamanian amyotrophic lateral sclerosis; AM1241, (2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone; AM404, N-(4- hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide; AMG517, N-[4-({6-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; AMG9678, (R)-1-(4-(trifluoromethyl)phenyl)-N-((S)-1,1,1-trifluoropropan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxamide; AMG9810, (2E)-N-(2,3- dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-propenamide;AMI,acutemyocardialinfarction;AMTB,N-(3-aminopropyl)-2-[3- methylphenyl)methoxy]-N-(2-thienylmethyl)benzamide hydrochloride; AP18, 4-(4-chlorophenyl)-3-methyl-3-buten-2-one oxime; Apo, apolipoprotein; ARD, ankyrin repeat domain; AS1928370, (R)-N-(1-methyl-2-oxo-1,2,3,4-tetrahydro-7-quinolyl)-2-[(2-methylpyrrolidin-1-yl)methyl]biphenyl-4-car- boxamide; AZD1386, (S)-N-{1-[4-(t-butyl)-phenyl]-ethyl}-2-(6,7-difluorobenzoimidazol-1-yl)acetamide; BAL, bronchoalveolar lavage; BAT, brown adipose tissue; BayK8644, methyl-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate; BCC, basal cell carcinoma; BCTC, N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine-1(2H)-carboxamide; BD-I, bipolar disorder type I; BDNF, brain-derived neurotrophic factor; BK, bradykinin; BTP2, N-{4-[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl}-4-methyl-1,2,3-thiadiazole-5-carboxamide; CaM, calmodulin; CaMKII, Ca2+/CaM-dependent kinase II; CB1, cannabinoid receptor 1; CCI, chronic constriction injury; CCK, cholecystokinin; CDK, cyclin-dependent kinase; CFA, complete Freund’s adjuvant; CGRP, calcitonin gene-related peptide; CHO, Chinese hamster ovary; CIPN, chemotherapy-induced peripheral neuropathy; CNS, central nervous system; COPD, chronic obstructive pulmonary disease; COX, cyclooxygenase; CRP, C-reactive protein; CSE, cigarette smoke extract; D-3263, 3-(2-amino-ethyl)-1(R)-[(2(S)-isopropyl-5(R)-methyl cyclohexanecarbonyl)]-5-methoxy- 1,3-dihydro-benzoimidazol-2-one hydrochloride; DAG, diacylglycerol; DRG, dorsal root ganglion; EGF, epidermal growth factor; EGFR, epidermal growth factor receptor; EPSP, excitatory postsynaptic potential; ERK, extracellular signal-regulated kinase; FD, functional dyspepsia; FDA, US Food and Drug Administration; FK506, tacrolimus; FSGS, focal segmental glomerulosclerosis; GBM, glioblastoma multiforme; GERD, gastroesophageal reflux disease; GLP-1, glucagon-like peptide-1; GPCR, G protein–coupled receptor; GRP, gastrin-releasing peptide; GSK1016790A, (N-((1S)-1-{[4- ((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carbox- amide; GSK205, N-(4-(2-(benzyl(methyl)amino)ethyl)phenyl)-5-(pyridine-3-yl)thiazol-2-amine; H2S, hydrogen sulfide; HC-030031, 2-(1,3-dimethyl-2, 6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide; HC-067047, 2-methyl-1-[3-(4-morpholinyl)propyl]-5-phenyl-N-[3-(trifluoro- methyl)phenyl]-1H-pyrrole-3-carboxamide; HCAEC, coronary artery endothelial cell of human origin; hIAP, human islet amyloid polypeptide; HMVEC, human microvascular endothelial cell; HPETE, 12-(S)-5-hydroperoxyeicosatetraenoic acid; HSH, hypomagnesemia with secondary hypocalcemia; IBD, inflammatory bowel disease; IGF, insulin-like growth factor; IL, interleukin; IFN, interferon; iNOS, inducible nitric-oxide synthase; IP3,inositol- 1,4,5-triphosphate; IPAH, idiopathic pulmonary arterial hypertension; IPF, idiopathic pulmonary fibrosis; I-RTX, 5-iodoresiniferatoxin; JNJ17203212, 4-[3-(trifluoromethyl)-2-pyridinyl]-N-[5-(trifluoromethyl)-2-pyridinyl]-1-piperazinecarboxamide; JNJ41876666, 3-[7-trifluoromethyl-5-(2-trifluorome- thyl-phenyl)-1H-benzimidazol-2-yl]-1-oxa-2-aza-spiro[4.5]dec-2-ene hydrochloride; JYL1421, N-(4-tertbutylbenzyl)-N-[3-fluoro-4-(methylsulfonylamino) benzyl]-thiourea; KIF13B, kinesin-3 family member 13B; LA, linoleic acid; LPS, lipopolysaccharide; LTB4, leukotriene B4; LTD, long-term depression; LTP, long-term potentiation; MCP1, macrophage
Load more

Recommended publications
  • A Computational Model of Large Conductance Voltage and Calcium
    Journal of Computational Neuroscience (2019) 46:233–256 https://doi.org/10.1007/s10827-019-00713-9 A computational model of large conductance voltage and calcium activated potassium channels: implications for calcium dynamics and electrophysiology in detrusor smooth muscle cells Suranjana Gupta1 · Rohit Manchanda1 Received: 11 September 2018 / Revised: 14 February 2019 / Accepted: 19 February 2019 / Published online: 25 April 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract The large conductance voltage and calcium activated potassium (BK) channels play a crucial role in regulating the excitability of detrusor smooth muscle, which lines the wall of the urinary bladder. These channels have been widely characterized in terms of their molecular structure, pharmacology and electrophysiology. They control the repolarising and hyperpolarising phases of the action potential, thereby regulating the firing frequency and contraction profiles of the smooth muscle. Several groups have reported varied profiles of BK currents and I-V curves under similar experimental conditions. However, no single computational model has been able to reconcile these apparent discrepancies. In view of the channels’ physiological importance, it is imperative to understand their mechanistic underpinnings so that a realistic model can be created. This paper presents a computational model of the BK channel, based on the Hodgkin-Huxley formalism, constructed by utilising three activation processes — membrane potential, calcium inflow from voltage-gated calcium channels on the membrane and calcium released from the ryanodine receptors present on the sarcoplasmic reticulum. In our model, we attribute the discrepant profiles to the underlying cytosolic calcium received by the channel during its activation. The model enables us to make heuristic predictions regarding the nature of the sub-membrane calcium dynamics underlying the BK channel’s activation.
    [Show full text]
  • 1 TRP About Online
    a TR P to Spain International Workshop on Transient Receptor Potential Channels 12th – 14th September 2012 Valencia, Spain www.trp2012.com SCHEDULE and ABSTRACTS BOOK September 2012 Dear participants, Travelling to faraway places in search of spiritual or cultural enlightenment is a millennium old human activity. In their travels, pilgrims brought with them news, foods, music and traditions from distant lands. This friendly exchange led to the cultural enrichment of visitors and the economic flourishing of places, now iconic, such as Rome, Santiago, Jerusalem, Mecca, Varanasi or Angkor Thom. The dissemination of science and technology also benefited greatly from these travels to remote locations. The new pilgrims of the Transient Receptor Potential (TRP) community are also very fond of travelling. In the past years they have gathered at various locations around the globe: Breckenridge (USA), Eilat (Israel), Stockholm (Sweden) and Leuven (Belgium) come to mind. These meetings, each different and exciting, have been very important for the dissemination of TRP research. We are happy to welcome you in Valencia (Spain) for TRP2012. The response to our call has been extraordinary, surpassing all our expectations. The speakers, the modern bards, readily attended our request to communicate their new results. At last count we were already more than 170 participants, many of them students, and most presenting their recent work in the form of posters or short oral presentations. At least 25 countries are sending TRP ambassadors to Valencia, making this a truly international meeting. We like to thank the staff of the Cátedra Santiago Grisolía, Fundación Ciudad de las Artes y las Ciencias for their dedication and excellence in handling the administrative details of the workshop.
    [Show full text]
  • Targeting the Endocannabinoid System to Reduce Nociception
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2011 Targeting the endocannabinoid system to reduce nociception Lamont Booker Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medical Pharmacology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/2419 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. Targeting the Endocannabinoid System to Reduce Nociception A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University. By Lamont Booker Bachelor’s of Science, Fayetteville State University 2003 Master’s of Toxicology, North Carolina State University 2005 Director: Dr. Aron H. Lichtman, Professor, Pharmacology & Toxicology Virginia Commonwealth University Richmond, Virginia April 2011 Acknowledgements The author wishes to thank several people. I like to thank my advisor Dr. Aron Lichtman for taking a chance and allowing me to work under his guidance. He has been a great influence not only with project and research direction, but as an excellent example of what a mentor should be (always willing to listen, understanding the needs of each student/technician, and willing to provide a hand when available). Additionally, I like to thank all of my committee members (Drs. Galya Abdrakmanova, Francine Cabral, Sandra Welch, Mike Grotewiel) for your patience and willingness to participate as a member. Our term together has truly been memorable! I owe a special thanks to Sheryol Cox, and Dr.
    [Show full text]
  • Perception of Facial Expressions in Social Anxiety and Gaze Anxiety
    The Pegasus Review: UCF Undergraduate Research Journal (URJ) Volume 9 Issue 1 Article 6 2016 Perception of Facial Expressions in Social Anxiety and Gaze Anxiety Aaron Necaise University of Central Florida, [email protected] Part of the Psychology Commons Find similar works at: https://stars.library.ucf.edu/urj University of Central Florida Libraries http://library.ucf.edu This Article is brought to you for free and open access by the Office of Undergraduate Research at STARS. It has been accepted for inclusion in The Pegasus Review: UCF Undergraduate Research Journal (URJ) by an authorized editor of STARS. For more information, please contact [email protected]. Recommended Citation Necaise, Aaron (2016) "Perception of Facial Expressions in Social Anxiety and Gaze Anxiety," The Pegasus Review: UCF Undergraduate Research Journal (URJ): Vol. 9 : Iss. 1 , Article 6. Available at: https://stars.library.ucf.edu/urj/vol9/iss1/6 Necaise: Perception of Facial Expressions Social Anxiety & Gaze Anxiety Published Vol. 9.1: 40-47 October 19th, 2017 THE UNIVERSITY OF CENTRAL FLORIDA UNDERGRADUATE RESEARCH JOURNAL Analysis of the Pathomechanism and Treatment of Migraines Related to the Role of the Neuropeptide CGRP By: Marvi S. Qureshi Faculty Mentor: Dr. Mohtashem Samsam UCF Burnett School of Biomedical Sciences ABSTRACT: Migraines are a type of headache that specifically act on only one side of the head, although about 30% of patients with migraines may experience a bilateral headache. Migraines are brain disorders that typically involve issues of sensory processing taking place in the brainstem. Possible causation has been linked to blood vessels, blood flow, and oxygen levels in the brain.
    [Show full text]
  • Therapeutic Targets for the Treatment of Chronic Cough
    Therapeutic Targets for the Treatment of Chronic Cough Roe, N., Lundy, F., Litherland, G. J., & McGarvey, L. (2019). Therapeutic Targets for the Treatment of Chronic Cough. Current Otorhinolaryngology Reports. https://doi.org/10.1007/s40136-019-00239-9 Published in: Current Otorhinolaryngology Reports Document Version: Publisher's PDF, also known as Version of record Queen's University Belfast - Research Portal: Link to publication record in Queen's University Belfast Research Portal Publisher rights Copyright 2019 the authors. This is an open access article published under a Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited. General rights Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the Research Portal that you believe breaches copyright or violates any law, please contact [email protected]. Download date:25. Sep. 2021 Current Otorhinolaryngology Reports https://doi.org/10.1007/s40136-019-00239-9 CHRONIC COUGH (K ALTMAN, SECTION EDITOR) Therapeutic Targets for the Treatment of Chronic Cough N.
    [Show full text]
  • TRP Mediation
    molecules Review Remedia Sternutatoria over the Centuries: TRP Mediation Lujain Aloum 1 , Eman Alefishat 1,2,3 , Janah Shaya 4 and Georg A. Petroianu 1,* 1 Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] (L.A.); Eman.alefi[email protected] (E.A.) 2 Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates 3 Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, The University of Jordan, Amman 11941, Jordan 4 Pre-Medicine Bridge Program, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates; [email protected] * Correspondence: [email protected]; Tel.: +971-50-413-4525 Abstract: Sneezing (sternutatio) is a poorly understood polysynaptic physiologic reflex phenomenon. Sneezing has exerted a strange fascination on humans throughout history, and induced sneezing was widely used by physicians for therapeutic purposes, on the assumption that sneezing eliminates noxious factors from the body, mainly from the head. The present contribution examines the various mixtures used for inducing sneezes (remedia sternutatoria) over the centuries. The majority of the constituents of the sneeze-inducing remedies are modulators of transient receptor potential (TRP) channels. The TRP channel superfamily consists of large heterogeneous groups of channels that play numerous physiological roles such as thermosensation, chemosensation, osmosensation and mechanosensation. Sneezing is associated with the activation of the wasabi receptor, (TRPA1), typical ligand is allyl isothiocyanate and the hot chili pepper receptor, (TRPV1), typical agonist is capsaicin, in the vagal sensory nerve terminals, activated by noxious stimulants.
    [Show full text]
  • Potential Mechanisms of Prospective Antimigraine Drugs: a Focus on Vascular (Side) Effects
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Pharmacology & Therapeutics 129 (2011) 332–351 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Associate Editor: John Fozard Potential mechanisms of prospective antimigraine drugs: A focus on vascular (side) effects Kayi Y. Chan a, Steve Vermeersch b, Jan de Hoon b, Carlos M. Villalón c, Antoinette MaassenVanDenBrink a,⁎ a Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands b Center for Clinical Pharmacology, University Hospitals Leuven, Campus Gasthuisberg, (K.U. Leuven), Leuven, Belgium c Departamento de Farmacobiología, Cinvestav-Coapa, Czda. de los Tenorios 235, Col. Granjas-Coapa, Deleg. Tlalpan, C.P. 14330, México D.F., Mexico article info abstract Available online 2 December 2010 Currently available drugs for the acute treatment of migraine, i.e. ergot alkaloids and triptans, are cranial vasoconstrictors. Although cranial vasoconstriction is likely to mediate—at least a part of—their therapeutic Keywords: effects, this property also causes vascular side-effects. Indeed, the ergot alkaloids and the triptans have been Antimigraine drugs reported to induce myocardial ischemia and stroke, albeit in extremely rare cases, and are contraindicated in Neuropeptides patients with known cardiovascular risk factors. In view of these limitations, novel antimigraine drugs
    [Show full text]
  • Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic
    ANTICANCER RESEARCH 37 : 161-168 (2017) doi:10.21873/anticanres.11301 Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells I-TSANG CHIANG 1,2,3* , WEI-TING CHEN 4* , CHIH-WEI TSENG 5, YEN-CHUNG CHEN 2,6 , YU-CHENG KUO 7, BI-JHIH CHEN 8, MAO-CHI WENG 9, HWAI-JENG LIN 10,11# and WEI-SHU WANG 2,12,13# Departments of 1Radiation Oncology, 6Pathology, and 13 Medicine, and 2Cancer Medical Care Center, National Yang-Ming University Hospital, Yilan, Taiwan, R.O.C.; 3Department of Radiological Technology, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.; 4Department of Psychiatry, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, R.O.C.; 5Division of Gastroenterology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan, R.O.C.; 7Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.; 8Department of Laboratory Medicine, Changhua Christian Hospital, Changhua Christian Medical Foundation, Changhua, Taiwan, R.O.C.; 9Institute of Nuclear Energy Research, Atomic Energy Council, Taoyuan, Taiwan, R.O.C.; 10 Department of Internal Medicine, Division of Gastroenterology and Hepatology, College of Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan, R.O.C.; 11 Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shuang-Ho Hospital, New Taipei, Taiwan, R.O.C.; 12 National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C. Abstract. The aim of the present study was to investigate the (c-FLIP), X-linked inhibitor of apoptosis protein (XIAP), antitumor effect and mechanism of action of hyperforin in myeloid cell leukemia 1(MCL1), and cyclin-D1] were hepatocellular carcinoma (HCC) SK-Hep1 cells in vitro.
    [Show full text]
  • The Intracellular Ca2+ Release Channel TRPML1 Regulates Lower Urinary Tract Smooth Muscle Contractility
    The intracellular Ca2+ release channel TRPML1 regulates lower urinary tract smooth muscle contractility Caoimhin S. Griffina, Michael G. Alvaradoa, Evan Yamasakia, Bernard T. Drummb,c, Vivek Krishnana, Sher Alia, Eleanor M. Naglea, Kenton M. Sandersb, and Scott Earleya,1 aDepartment of Pharmacology, Center for Molecular and Cellular Signaling in the Cardiovascular System, Reno School of Medicine, University of Nevada, Reno, NV 89557-0318; bDepartment of Physiology and Cell Biology, Reno School of Medicine, University of Nevada, Reno, NV 89557-0318; and cDepartment of Life & Health Sciences, Dundalk Institute of Technology, Louth, Ireland A91 K584 Edited by Mark T. Nelson, University of Vermont, Burlington, VT, and approved October 13, 2020 (received for review August 12, 2020) TRPML1 (transient receptor potential mucolipin 1) is a Ca2+-perme- including dense granulomembranous storage bodies in neurons, able, nonselective cation channel that is predominantly localized to elevated plasma gastrin, vacuolization in the gastric mucosa, and the membranes of late endosomes and lysosomes (LELs). Intracellular retinal degeneration (14). Interestingly, however, an anatomical release of Ca2+ through TRPML1 is thought to be pivotal for mainte- examination of these mice reveals dramatically distended bladders nance of intravesicular acidic pH as well as the maturation, fusion, and (14), leading us to question how TRPML1, an intracellular Ca2+- trafficking of LELs. Interestingly, genetic ablation of TRPML1 in mice release channel important in LEL function, affects bladder −/− (Mcoln1 ) induces a hyperdistended/hypertrophic bladder phenotype. physiology. Here, we investigated this phenomenon further by exploring an un- The lower urinary tract (LUT) is composed of the urinary conventional role for TRPML1 channels in the regulation of Ca2+-signal- bladder and urethra—structures that serve the simple, reciprocal ing activity and contractility in bladder and urethral smooth muscle cells functions of storing and voiding urine (15).
    [Show full text]
  • WO 2013/142184 Al 26 September 2013 (26.09.2013) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/142184 Al 26 September 2013 (26.09.2013) P O P C T (51) International Patent Classification: DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, A61K 33/16 (2006.01) A61K 31/7048 (2006.01) HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, A61K 33/14 (2006.01) A61K 31/70 (2006.01) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, A61K 33/18 (2006.01) A61K 31/4196 (2006.01) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (21) International Application Number: RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, PCT/US20 13/030788 TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (22) International Filing Date: ZM, ZW. 13 March 2013 (13.03.2013) (84) Designated States (unless otherwise indicated, for every (25) Filing Language: English kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (26) Publication Language: English UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (30) Priority Data: TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 61/612,689 19 March 2012 (19.03.2012) US EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (71) Applicant: YALE UNIVERSITY [US/US]; Two Whitney TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, Avenue, New Haven, CT 065 10 (US).
    [Show full text]
  • Supplementary Materials Evodiamine Inhibits Both Stem Cell and Non-Stem
    Supplementary materials Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70 Seung Yeob Hyun, Huong Thuy Le, Hye-Young Min, Honglan Pei, Yijae Lim, Injae Song, Yen T. K. Nguyen, Suckchang Hong, Byung Woo Han, Ho-Young Lee - 1 - Table S1. Short tandem repeat (STR) DNA profiles for human cancer cell lines used in this study. MDA-MB-231 Marker H1299 H460 A549 HCT116 (MDA231) Amelogenin XX XY XY XX XX D8S1179 10, 13 12 13, 14 10, 14, 15 13 D21S11 32.2 30 29 29, 30 30, 33.2 D7S820 10 9, 12 8, 11 11, 12 8 CSF1PO 12 11, 12 10, 12 7, 10 12, 13 D3S1358 17 15, 18 16 12, 16, 17 16 TH01 6, 9.3 9.3 8, 9.3 8, 9 7, 9.3 D13S317 12 13 11 10, 12 13 D16S539 12, 13 9 11, 12 11, 13 12 D2S1338 23, 24 17, 25 24 16 21 D19S433 14 14 13 11, 12 11, 14 vWA 16, 18 17 14 17, 22 15 TPOX 8 8 8, 11 8, 9 8, 9 D18S51 16 13, 15 14, 17 15, 17 11, 16 D5S818 11 9, 10 11 10, 11 12 FGA 20 21, 23 23 18, 23 22, 23 - 2 - Table S2. Antibodies used in this study. Catalogue Target Vendor Clone Dilution ratio Application1) Number 1:1000 (WB) ADI-SPA- 1:50 (IHC) HSP70 Enzo C92F3A-5 WB, IHC, IF, IP 810-F 1:50 (IF) 1 :1000 (IP) ADI-SPA- HSP90 Enzo 9D2 1:1000 WB 840-F 1:1000 (WB) Oct4 Abcam ab19857 WB, IF 1:100 (IF) Nanog Cell Signaling 4903S D73G4 1:1000 WB Sox2 Abcam ab97959 1:1000 WB ADI-SRA- Hop Enzo DS14F5 1:1000 WB 1500-F HIF-1α BD 610958 54/HIF-1α 1:1000 WB pAkt (S473) Cell Signaling 4060S D9E 1:1000 WB Akt Cell Signaling 9272S 1:1000 WB pMEK Cell Signaling 9121S 1:1000 WB (S217/221) MEK Cell Signaling 9122S 1:1000
    [Show full text]
  • Entropy-Based Regulation of Cluster Ion Channel Density
    www.nature.com/scientificreports OPEN Molecular and cellular correlates in Kv channel clustering: entropy‑based regulation of cluster ion channel density Limor Lewin1, Esraa Nsasra1, Ella Golbary1, Uzi Hadad2, Irit Orr1 & Ofer Yifrach1* Scafold protein-mediated ion channel clustering at unique membrane sites is important for electrical signaling. Yet, the mechanism(s) by which scafold protein-ion channel interactions lead to channel clustering or how cluster ion channel density is regulated is mostly not known. The voltage‑activated potassium channel (Kv) represents an excellent model to address these questions as the mechanism underlying its interaction with the post-synaptic density 95 (PSD-95) scafold protein is known to be controlled by the length of the extended ‘ball and chain’ sequence comprising the C-terminal channel region. Here, using sub-difraction high-resolution imaging microscopy, we show that Kv channel ‘chain’ length regulates Kv channel density with a ‘bell’-shaped dependence, refecting a balance between thermodynamic considerations controlling ‘chain’ recruitment by PSD-95 and steric hindrance due to the spatial proximity of multiple channel molecules. Our results thus reveal an entropy‑based mode of channel cluster density regulation that mirrors the entropy‑based regulation of the Kv channel-PSD-95 interaction. The implications of these fndings for electrical signaling are discussed. Action potential generation, propagation and the evoked synaptic potential all rely on precisely timed events associated with activation and inactivation gating transitions of voltage-dependent Na + and K + channels, clus- tered in multiple copies at unique membrane sites, such as the initial segment of an axon, nodes of Ranvier, pre-synaptic terminals or at the post-synaptic density (PSD)1–3.
    [Show full text]